Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
6,55
USD
|
+1,71%
|
|
+4,47%
|
+44,91%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
237,3
|
184,4
|
276,1
|
857,1
|
1.021
|
1.518
|
-
|
-
|
Bedrijfswaarde
1 |
237,3
|
184,4
|
276,1
|
857,1
|
1.021
|
1.518
|
1.518
|
1.518
|
K/w-verhouding
|
-4,49
x
|
-2,22
x
|
-2,76
x
|
-11,8
x
|
-34,8
x
|
22,2
x
|
13,1
x
|
11,2
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
8,08
x
|
4,37
x
|
3,41
x
|
5,56
x
|
3,96
x
|
4,55
x
|
3,89
x
|
3,51
x
|
Bedrijfswaarde/omzet
|
8,08
x
|
4,37
x
|
3,41
x
|
5,56
x
|
3,96
x
|
4,55
x
|
3,89
x
|
3,51
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
-
|
25,4
x
|
14,7
x
|
10,7
x
|
8,63
x
|
Bedrijfswaarde/FCF
|
-
|
-1,61
x
|
-2,41
x
|
-14,5
x
|
-
|
34,7
x
|
12,7
x
|
11,6
x
|
FCF Yield
|
-
|
-62,2%
|
-41,5%
|
-6,91%
|
-
|
2,88%
|
7,89%
|
8,64%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
59.318
|
94.548
|
195.814
|
220.903
|
225.968
|
231.772
|
-
|
-
|
Referentieprijs
2 |
4,000
|
1,950
|
1,410
|
3,880
|
4,520
|
6,550
|
6,550
|
6,550
|
Datum van publicatie
|
12/03/20
|
25/03/21
|
24/03/22
|
23/03/23
|
28/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
29,35
|
42,22
|
80,94
|
154,1
|
258,2
|
333,8
|
390
|
432,3
|
EBITDA
1 |
-
|
-
|
-
|
-
|
40,25
|
103,2
|
141,8
|
176
|
Bedrijfsresultaat (EBIT)
1 |
-41,42
|
-64,91
|
-58,37
|
-39,37
|
21,63
|
82,12
|
128,1
|
148,7
|
Operationele Marge
|
-141,14%
|
-153,75%
|
-72,12%
|
-25,55%
|
8,38%
|
24,6%
|
32,86%
|
34,41%
|
Resultaat voor belastingen (EBT)
1 |
-48,28
|
-75,75
|
-55
|
-65,9
|
-28,24
|
67,38
|
116,5
|
141,8
|
Nettowinst (verlies)
1 |
-48,28
|
-75,75
|
-71,65
|
-65,9
|
-28,24
|
67,38
|
113,9
|
135,1
|
Nettomarge
|
-164,5%
|
-179,41%
|
-88,52%
|
-42,77%
|
-10,94%
|
20,19%
|
29,22%
|
31,25%
|
WPA
2 |
-0,8900
|
-0,8800
|
-0,5100
|
-0,3300
|
-0,1300
|
0,2950
|
0,5000
|
0,5833
|
Free Cash Flow
1 |
-
|
-114,7
|
-114,6
|
-59,23
|
-
|
43,7
|
119,8
|
131,2
|
FCF-marge
|
-
|
-271,74%
|
-141,56%
|
-38,44%
|
-
|
13,09%
|
30,73%
|
30,34%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
42,32%
|
84,49%
|
74,52%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
64,85%
|
105,18%
|
97,08%
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12/03/20
|
25/03/21
|
24/03/22
|
23/03/23
|
28/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
20,68
|
26,38
|
29,1
|
33,91
|
41,05
|
49,98
|
56,91
|
60,12
|
67,27
|
73,9
|
77,28
|
81,28
|
85,65
|
89,68
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
6,433
|
12,75
|
18,6
|
19,1
|
22,05
|
32,7
|
29,35
|
Bedrijfsresultaat (EBIT)
1 |
-14,44
|
-13,19
|
-14,82
|
-9,175
|
-9,317
|
-6,059
|
-0,8133
|
-0,4731
|
8,685
|
14,24
|
16,38
|
19,18
|
26,25
|
23,92
|
Operationele Marge
|
-69,81%
|
-50%
|
-50,91%
|
-27,06%
|
-22,69%
|
-12,12%
|
-1,43%
|
-0,79%
|
12,91%
|
19,26%
|
21,19%
|
23,59%
|
30,65%
|
26,68%
|
Resultaat voor belastingen (EBT)
1 |
-17,71
|
-16,65
|
-25,01
|
-13,76
|
-14,9
|
-12,23
|
-6,789
|
-6,371
|
2,565
|
-17,64
|
12,43
|
15,44
|
22,61
|
20,47
|
Nettowinst (verlies)
1 |
-17,71
|
-16,65
|
-25,01
|
-13,76
|
-14,9
|
-12,23
|
-6,789
|
-6,371
|
2,565
|
-17,64
|
12,43
|
15,44
|
22,61
|
20,47
|
Nettomarge
|
-85,65%
|
-63,11%
|
-85,93%
|
-40,6%
|
-36,29%
|
-24,47%
|
-11,93%
|
-10,6%
|
3,81%
|
-23,87%
|
16,09%
|
19%
|
26,4%
|
22,83%
|
WPA
2 |
-0,1300
|
-0,0700
|
-0,1300
|
-0,0700
|
-0,0800
|
-0,0600
|
-0,0300
|
-0,0300
|
0,0100
|
-0,0800
|
0,0550
|
0,0700
|
0,0975
|
0,0900
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/11/21
|
24/03/22
|
11/05/22
|
10/08/22
|
9/11/22
|
23/03/23
|
10/05/23
|
9/08/23
|
8/11/23
|
28/02/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-115
|
-115
|
-59,2
|
-
|
43,7
|
120
|
131
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
3,81
|
12,7
|
13,5
|
13,9
|
4,77
|
5
|
11
|
11,8
|
Capex/omzet
|
12,99%
|
30,14%
|
16,69%
|
9,03%
|
1,85%
|
1,5%
|
2,83%
|
2,74%
|
Datum van publicatie
|
12/03/20
|
25/03/21
|
24/03/22
|
23/03/23
|
28/02/24
|
-
|
-
|
-
|
Laatste slotkoers
6,55
USD Gemiddelde koersdoel
8,375
USD Spread / Gemiddelde doel +27,86% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +44,91% | 1,52 mld. | | -4,66% | 86,13 mld. | | +1,32% | 39,82 mld. | | -19,27% | 30,42 mld. | | +57,86% | 25,23 mld. | | -17,69% | 11,6 mld. | | -43,00% | 11,51 mld. | | -9,14% | 11,95 mld. | | +5,24% | 8,71 mld. | | -8,42% | 8,12 mld. |
Biofarmaceutica
|